AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
- Posted on April 24, 2026
- By Wired
- 0 Views
- 1 min read
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
